Here are seven recent news updates on gastroenterology and endoscopy companies.
EndoChoice closed $57 million in preferred equity financing. Deerfield led the financing round, with input from several other new and existing investors.
https://www.beckersasc.com/gastroenterology-and-endoscopy/endochoice-raises-57m-in-equity-financing.html
The American Medical Association announced the new Category I CPT code 432XX1, which will cover esophagogastric fundoplasty trans-orifice approach procedures. The code will be used to cover the Transoral Incisionless Fundoplication procedure from EndoGastric Solutions and procedures performed with the MUSE platform from Medigus.
Endo International made a takeover offer to Salix Pharmaceuticals, which already has an agreement to be bought by Valeant Pharmaceuticals International, according to a report by The Wall Street Journal.
Exact Sciences and Ironwood Pharmaceuticals entered into an agreement to co-promote Exact Sciences' Cologuard.
Physicians Endoscopy acquired a majority interest in the Philadelphia Gastroenterology Consultants Endoscopy Center of Excellence.
William P. Forbes, executive vice president with Salix Pharmaceuticals, sold 20,000 shares of company stock for a total transaction value of $3.16 million, according to a report by The Legacy.
The FDA approved the REZA BAND from Somna Therapeutics. The REZA BAND applies slight pressure to the neck to reduce laryngopharyngeal reflux symptoms.
If you have a question, issue or note to suggest on a GI/endoscopy company please contact Carrie Pallardy at cpallardy@beckershealthcare.com.